Skip to content
Ontario Rheumatology Association
  • Login
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • Informatics
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Directory
    • Peer Mentor Forum
    • Resource for Members
    • Become A Member
    • Renew Membership
    • Membership Perks
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • Informatics
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Directory
    • Peer Mentor Forum
    • Resource for Members
    • Become A Member
    • Renew Membership
    • Membership Perks
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory

President’s Message

Henry Averns • Edition: Spring 2019

Our upcoming AGM represents the realization of a vision and hundreds of hours of work by the AGM committee to bring together a completely new academic and networking event, which can compete with international conferences in terms of content and speakers. If you have not registered, then read no further and get it done now! You will also have seen the newly designed website and our new Peer Mentor Forum which I would urge you to explore and join.

18 months ago the new OHIP + was announced with a fanfare, and it seemed that this was a positive step for all young patients. Move forward to this month and we discover a revised two tier system which discriminates against young patients who have any sort of medical insurance and which will undoubtedly financially disadvantage some families. Please refer to our website for FAQs on OHIP+.

The ORA strongly recommended that the need for some children to apply for Trillium was unfair and overly complex but our contribution to the consultation process sadly did not result in a better outcome. If your patients are disadvantaged by the new model we would like to hear from you – please write to me or Denis Morrice.

I am truly disappointed by the new OHIP+. Trillium may seem simple to many, but an application requires access to a process and a level of literacy, that many patients do not have. In addition it is recognized that many pharmacists and doctors have a rudimentary and often incorrect perception of who can apply for Trillium. For those who are unsure please refer to the guide below which you can print out to show your patients.

This will be my last letter as President. I wish to thank the ORA Board for their considerable patience and kindness as they mentored me through the last three years, but most of all I wish to thank Sandy Kennedy who has been the beating heart of the ORA since she started, and who has guided me on a daily basis.

Trillium 2

Other Articles in the Spring 2019 Newsletter

  • Emerging Rheumatologists of Ontario
  • Informatics Update
  • General Committee Updates
  • OMA Section on Rheumatology Report
  • Communications Update
  • 18th Annual Meeting at the Kingbridge Conference Centre
Editions
  • Winter 2021
  • Fall 2020
  • Summer 2020
  • Winter 2020
  • Winter 2019
  • Fall 2019
  • Spring 2019
  • Winter 2018
  • Fall 2018
  • Summer 2018
  • Summer 2017
  • Spring 2017
  • Fall 2017
  • Archive
  • Meet the Speakers: ORA 20th Annual Scientific Meeting
Committees
Communications Informatics Models of Care OMA
Tags
Biosimilar CSDTH Models of Care OBRI OMA pCPA SADIE

Contributors

The ORA’s executive members are the core contributors to the newsletter. The ORA welcomes guest contributions to the newsletter from members-at-large and others in the rheumatology community.

Contributors
Ontario Rheumatology Association

© 2020 Ontario Rheumatology Association. All Rights Reserved. Website by Digital Chaos Inc.

  • About
  • Annual Awards
  • Events
  • EAP & Limited Use Codes
  • Exceptional Access Program
  • EAP Forms and Downloads
  • Limited Use Codes
  • Biosimilar Fact Sheet
  • NIHB Drug List
  • MOHLTC IVIG Request Form
  • Informatics
  • Members
  • Member Directory
  • Past Meeting Resources
  • Peer Mentor Forum
  • BecomeA Member
  • Renew Membership
  • News
  • Newsletters
  • Drug Shortages Info
  • Other Publications
  • Info Hub
  • Contact
  • Privacy